In this regard, it was proved that CSF α-syn levels at 12 months were lower in PD patients treated with dopamine replacement therapy, especially dopamine agonists, but no significant relationships were found with t-Tau and p-Tau levels [108]. Here, MAPT is linked to Parkinson disease.